Marimed (MRMD) Cash from Investing Activities Growth (5y) (2017 - 2026)
Marimed (MRMD) Cash from Investing Activities Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.19% |
| Mar 31, 2026 | 23.52% |
| Dec 31, 2025 | 18.12% |
| Sep 30, 2025 | 17.67% |
| Jun 30, 2025 | 14.54% |
| Mar 31, 2025 | 38.93% |
| Dec 31, 2024 | 18.09% |
| Sep 30, 2024 | 11.22% |
| Jun 30, 2024 | -22.95% |
| Mar 31, 2024 | -15.97% |
| Dec 31, 2023 | 24.39% |
| Sep 30, 2023 | 6.37% |
| Jun 30, 2023 | -7.83% |
| Mar 31, 2023 | -40.07% |
| Dec 31, 2022 | 23.27% |
| Sep 30, 2022 | 19.44% |
| Jun 30, 2022 | -53.80% |
| Mar 31, 2022 | -19.49% |
| Dec 31, 2021 | -215.85% |
| Sep 30, 2021 | -21.86% |